EGF and neoplasm: Since EGF, a ligand of receptor tyrosine kinase, is widely reported to promote tumor growth, cell proliferation and apoptosis deregulation through activation of its downstream signaling, including MEK/ERK [25], we clarified whether 22-(4′py)-JA was able to suppress MEK/ERK signaling mediated by EGF.